|Small Diagnostics Company Aims To Change Lab Field Testing (OTC:BMGP)|
|Wednesday, 14 October 2009 03:00|
Diagnostics, the technologies and tools used to identify diseases and conditions in patients make up the second-largest portion of the biotechnology industry. A new technology, originally developed with funding from the Department of Homeland Security, allows laboratories to perform far more tests in the same amount of time it takes to do a single test and is designed to detect the actual virus and viral load in any body fluid.
Biomagnetics Diagnostics Corp. (OTC:BMGP) is a producer of revolutionary diagnostic systems and technology for malaria, tuberculosis, HIV and hepatitis testing.
The company has made it one of their goals to provide innovative products to meet this demand and to deploy their testing equipment and technologies in the field as well as in the clinical setting for a wide variety of pathogens.
Joe Noel, who introduced many investors to BioElectronics Corporation, tells us about this intriguing penny stock play within the diagnostics space.
A special, in-depth audio interview can be heard below (click on the player under the image):